Start for free
Start for free
ME

Medical Excellence Capital

North America, New York, United States, New York

Description

Medical Excellence Capital is an early stage life sciences fund.

Investor Profile

Medical Excellence Capital has made 10 investments, with 3 in the past 12 months and 30% as lead.

Stage Focus

  • Series A (30%)
  • Series B (30%)
  • Seed (30%)
  • Series Unknown (10%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Biopharma
  • Therapeutics
  • Medical
  • Life Science
  • Health Diagnostics
  • Pharmaceutical
  • Genetics
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Medical Excellence Capital frequently co-invest with?

Eli Lilly & Company Foundation
Eli Lilly & Company Foundation
North America, Indiana, United States, Indianapolis
Co-Investments: 1
Foothill Ventures
Foothill Ventures
North America, California, United States, Los Altos
Co-Investments: 1
Johnson & Johnson Innovation – JJDC
Johnson & Johnson Innovation – JJDC
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Alexandria Venture Investments
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 4
NS Investment
NS Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
LI
Lifespan Investments
North America, Kentucky, United States, California
Co-Investments: 1
Vertex Ventures HC
Vertex Ventures HC
North America, California, United States, Palo Alto
Co-Investments: 1
Illumina Ventures
Illumina Ventures
North America, California, United States, Foster City
Co-Investments: 1
Formic Ventures
Formic Ventures
North America, California, United States, San Francisco
Co-Investments: 1
ARCH Venture Partners
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 2

What are some of recent deals done by Medical Excellence Capital?

Pleno

San Diego, California, United States

Pleno is a biotechnology company that aims speeding up disease diagnosis and treatment.

BiopharmaBiotechnologyHealth CareHealth Diagnostics
Series BDec 12, 2024
Amount Raised: $25,000,000
GC Therapeutics

Boston, Massachusetts, United States

GC Therapeutics uses synthetic biology to program patient-derived stem cells into various cell types in an efficient and scalable manner.

BiotechnologyLife ScienceTherapeutics
Series ASep 19, 2024
Amount Raised: $65,000,000
Truvian Sciences

San Diego, California, United States

Truvian Sciences develops an automated benchtop system to provide lab-accurate blood testing results.

BiotechnologyHealth CareHealth DiagnosticsLife ScienceMedical Device
Series UnknownJul 17, 2024
Amount Raised: $74,000,000
ProJenX

New Suffolk, New York, United States

ProJenX is a biopharmaceutical company that develops novel small molecule therapeutics that target motor neuron degenerative pathways.

BiopharmaBiotechnologyHealth CareTherapeutics
Series ANov 2, 2023
Amount Raised: $15,000,000
Avilar Therapeutics

Waltham, Massachusetts, United States

Avilar Therapeutics is a biopharmaceutical company focusing on extracellular protein degradation.

BiotechnologyMedicalPharmaceutical
SeedFeb 16, 2023
Amount Raised: $15,000,000
SonoThera

San Francisco, California, United States

SonoThera is a biotechnology company that creates non-viral genetic therapies using ultrasound.

BiopharmaBiotechnologyGeneticsMedical
Series ADec 5, 2022
Amount Raised: $60,750,000
Pleno

San Diego, California, United States

Pleno is a biotechnology company that aims speeding up disease diagnosis and treatment.

BiopharmaBiotechnologyHealth CareHealth Diagnostics
SeedMay 25, 2022
Amount Raised: $15,000,000
Aspen Neuroscience

San Diego, California, United States

Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies.

BiotechnologyMedicalPharmaceuticalTherapeutics
Series BMay 9, 2022
Amount Raised: $147,500,000
ProJenX

New Suffolk, New York, United States

ProJenX is a biopharmaceutical company that develops novel small molecule therapeutics that target motor neuron degenerative pathways.

BiopharmaBiotechnologyHealth CareTherapeutics
SeedFeb 16, 2022
Amount Raised: $5,100,000
Immunitas Therapeutics

Cambridge, Massachusetts, United States

Immunitas Therapeutics is a single cell genomics-based drug discovery company that modulates oncology targets.

BiotechnologyHealth CareLife ScienceOncologyTherapeutics
Series BAug 18, 2021
Amount Raised: $58,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator